MICROPORT (00853): Shanghai Microport Endovascular Medtech Reports H1 Net Profit of Approximately RMB 315 Million, Down 22.03% YoY

Stock News
08/26

MICROPORT (00853) announced the first half 2025 financial results for Shanghai Microport Endovascular Medtech(Group)Co.,Ltd., showing revenue of approximately RMB 714 million, representing a year-over-year decrease of 9.24%. Net profit attributable to Shanghai Microport Endovascular Medtech(Group)Co.,Ltd. shareholders reached approximately RMB 315 million, down 22.03% compared to the same period last year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10